Akoya Biosciences (NASDAQ: AKYA) Enters Merger Agreement with Quanterix Corporation

Akoya Biosciences, Inc., a Delaware corporation, announced on January 9, 2025, its entry into an Agreement and Plan of Merger with Quanterix Corporation, a Delaware corporation, along with Wellfleet Merger Sub, Inc., a wholly-owned subsidiary of Quanterix. This merger agreement will lead to Akoya merging with and into Quanterix, with Akoya continuing as Quanterix’s wholly-owned […]

Leave a Reply

Your email address will not be published.

Previous post Bioxytran (OTCMKTS:BIXT) to Release Cancer Preprint Revealing Potential Immunotherapy EnhancementOn January 10, 2025, Bioxytran Inc., a clinical-stage biotechnology company focused on developing oral and intravenous drugs for various conditions, anno
Next post CRH Completes Offering of Guaranteed Notes, CRH America Finance and SMW Finance DAC Issue SecuritiesCRH public limited company, listed on the New York Stock Exchange under the ticker CRH, recently completed a notable offering of U.S. Dollar Guarantee